moxalactam has been researched along with cefoperazone in 109 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 101 (92.66) | 18.7374 |
1990's | 4 (3.67) | 18.2507 |
2000's | 1 (0.92) | 29.6817 |
2010's | 3 (2.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Grime, K; Paine, SW | 1 |
Matthias, FR; Schäfer, H | 1 |
Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
Imamura, Y; Kodama, T; Matsuura, Y; Miyamoto, K; Murakami, Y; Sewake, H; Takesue, Y; Tsumura, H; Yokoyama, T | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Hasegawa, S; Hattori, R; Kinukawa, T; Matsuura, O; Ohshima, S; Ono, Y; Takeuchi, N | 1 |
Adam, D; Naber, K; Schäfer, H | 1 |
Durgham, SM; Ishag, AH; Shibl, AM | 1 |
Hejmanowski, LG; Rigan, D; Schentag, JJ; Walawander, C; Welage, LS; Williams, JS; Wilton, JH | 1 |
Bruckner, DA; Champlin, RE; Gale, RP; Ho, WG; Winston, DJ | 1 |
Drusano, G; McNamee, W; Ryan, P; Schimpff, S; Standiford, H; Tatem, B | 1 |
Noel, GJ; Teele, DW | 1 |
Marks, MI; Parker, KM; Stutman, HR | 1 |
Adelman, MH; Grasela, TH; Rigan, D; Schentag, JJ; Welage, LS; Williams, JS; Wilton, JH | 1 |
Johnson, JT; Yu, VL | 1 |
Eichenwald, HF | 1 |
Jehl, F; Monteil, H | 1 |
Imanaka, M; Matsumoto, M; Ogita, S; Oka, T; Sugawa, T | 1 |
Hirai, Y; Imamura, K; Kudo, H; Kumasaka, Y; Makino, I; Miyazawa, T; Nakahata, H; Nakamura, T; Takebe, K | 2 |
Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
Carson, PB; Moritz, VA | 1 |
Howell, AW; Jorgensen, JH; Redding, JS | 1 |
Christmann-Kleiss, U; Freundt, KJ; Schreiner, E | 1 |
Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
Cowles, LS; Johnson, JD; Raff, MJ; Reid, KH; Shields, CB | 1 |
Charles, D; Larsen, B | 1 |
Ma, MY; Rho, JP | 1 |
Hayashi, Y; Nakamura, K; Shimada, J | 1 |
Adams, CR; Anderson, EL; Robinson, PA; Tu, KK | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 1 |
Marsh, TD | 1 |
Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
Barza, M; Noble, JT | 1 |
Jones, RN | 1 |
Chu, KW; Fan, ST; Lau, WY; Suen, HC; Wong, KK; Yiu, TF | 1 |
Flux, M; Kramer, J; Laferriere, C; Marks, MI; Stutman, HR | 1 |
Barriere, SL; Mordenti, J; Ozasa, DC | 1 |
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
Iida, K; Iwanaga, T; Nakanishi, H; Yamada, H; Yamaguchi, M | 1 |
DeVito, JM; John, JF | 1 |
Aber, RC; Al-Mondhiry, HA; Caputo, GM; Weitekamp, MR | 1 |
Drusano, GL; Koch, TR; Kroll, MH; Warren, JW | 1 |
File, TM; Salstrom, SJ; Tan, JS | 1 |
Aikawa, N; Ishibiki, K | 1 |
Drusano, GL; McNamee, W; Standiford, HC; Tatem, BA | 1 |
Bégué, P; Lasfargues, G; Quinet, B; Quiniou, F; Safran, C | 1 |
Lipsky, JJ | 1 |
Daschner, FD; Mählmann, M; Metzger, M; Steffens, A | 1 |
Marks, MI; Tarpay, MM; Welch, DF | 1 |
Johnson, CE; Pennington, JE; Platt, R | 1 |
Parks, DB; Uri, JV | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Gerding, DN; Hall, WH; Opfer, BJ | 1 |
Durack, DT; Lang, SD | 1 |
Baker, CN; Jones, RN; Thornsberry, C | 1 |
Durack, DT; Edwards, DJ; Lang, SD | 1 |
Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
Bryk, DA; Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Durosoir, JL; Saliou, P; Thabaut, A | 1 |
Durack, DT; Perfect, JR | 2 |
Slack, MP | 1 |
Fox, JM; Quall, CO; Woolfrey, BF | 1 |
Livermore, DM; Williams, JD; Williams, RJ | 1 |
Fu, KP; Neu, HC | 1 |
Forsgren, A | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Brogard, JM; Comte, F | 1 |
Weinstein, AJ | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Grimm, L; McCracken, GH; Nelson, JD | 1 |
Labthavikul, P; Neu, HC | 1 |
Neu, HC | 2 |
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
Peters, G; Pulverer, G | 1 |
Craig, WA; Greenfield, RA; Kurzynski, TA | 1 |
Chanal, M; Cluzel, R; Glanddier, Y; Sirot, D; Sirot, J | 1 |
Baumgärtner, M; Grehn, M; Wundt, W | 1 |
Drew, WL; Mintz, L | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Bergeron, MG; Simard, P | 1 |
Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
Nightingale, CH; Quintiliani, R | 1 |
Belmega, G; Borner, K; Jendroschek, T; Kemmerich, B; Koeppe, P; Lode, H | 1 |
Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
Marks, MI | 1 |
Garzone, P; Lyon, J; Yu, VL | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Meyer, RD; Pasiecznik, K | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 1 |
Cohen, SH; Demling, R; Franti, CE; Gunther, R; Hoeprich, PD; Merry, JM; Miner, DJ | 1 |
Jones, RN; Wilson, HW | 1 |
Calderwood, SB; Jackson, E; Tung, CC | 1 |
Asari, S; Hayashi, C; Horikawa, M; Koda, K; Miyai, K; Shimizu, Y; Tsukamoto, H | 1 |
Inamatsu, T; Matsuda, T; Shimada, K; Urayama, K | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
Bulger, RR; Washington, JA | 1 |
Bongaerts, GP; Bruggeman-Ogle, KM; Mouton, RP; van Gestel, M | 1 |
Harvengt, C | 1 |
Ji, JS; Quan, JJ; Wang, HP; Wang, Y; Wang, YF; Xu, YC; Yu, YS | 1 |
6 review(s) available for moxalactam and cefoperazone
Article | Year |
---|---|
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
Gram-positive superinfections following beta-lactam chemotherapy: the significance of the enterococcus.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Gram-Positive Bacteria; Humans; Imipenem; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus; Thienamycins | 1985 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
10 trial(s) available for moxalactam and cefoperazone
Article | Year |
---|---|
Relationship between vitamin K1 2,3-epoxide and vitamin K1 in patients treated with N-methyl-thiotetrazole cephalosporins.
Topics: Cefoperazone; Cefotaxime; Humans; Middle Aged; Moxalactam; Urinary Tract Infections; Vitamin K 1 | 1992 |
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.
Topics: Adult; Azoles; Cefoperazone; Cefotetan; Chromatography, High Pressure Liquid; Female; Hematocrit; Humans; Infusions, Intravenous; Male; Moxalactam; Tetrazoles | 1989 |
Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Bacterial Infections; Cefoperazone; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation; Thienamycins | 1988 |
Antibiotic use during major head and neck surgery.
Topics: Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Clindamycin; Clinical Trials as Topic; Double-Blind Method; Gentamicins; Head and Neck Neoplasms; Humans; Moxalactam; Premedication; Prospective Studies; Random Allocation | 1988 |
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.
Topics: Anti-Bacterial Agents; Appendectomy; Cefoperazone; Cefotaxime; Child; Clinical Trials as Topic; Double-Blind Method; Humans; Kinetics; Moxalactam; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1985 |
The effects of latamoxef, cefotaxime, and cefoperazone on platelet function and coagulation in normal volunteers.
Topics: Blood Coagulation; Blood Platelets; Cefoperazone; Cefotaxime; Humans; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time | 1985 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Moxalactam | 1983 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
93 other study(ies) available for moxalactam and cefoperazone
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |
Beta-lactamase in gram-negative rods: the relationship between penicillinase and R plasmids in gram-negative rods.
Topics: beta-Lactamases; Cefazolin; Cefmetazole; Cefoperazone; Cephalosporinase; Citrobacter; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Moxalactam; Penicillin G; Penicillinase; Pseudomonas aeruginosa; R Factors; Serratia marcescens | 1990 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of pipera
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftazidime; Doxycycline; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Fosfomycin; Moxalactam; Piperacillin; Sulbactam | 1990 |
[A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
Topics: Aged; Aged, 80 and over; Biological Transport; Cefoperazone; Cefotaxime; Chromatography, High Pressure Liquid; Humans; Male; Middle Aged; Moxalactam; Premedication; Prostate; Prostatectomy; Prostatic Hyperplasia | 1986 |
Comparative in vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Topics: Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Cross Infection; Gentamicins; Gram-Negative Bacteria; Moxalactam; Ticarcillin | 1989 |
Correlation of predicted serum bactericidal activities and values measured in volunteers.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Drug Evaluation; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus | 1986 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
Potential of moxalactam and other new antimicrobial agents for bilirubin-albumin displacement in neonates.
Topics: Anti-Bacterial Agents; Azlocillin; Aztreonam; Bilirubin; Binding Sites; Cefoperazone; Ciprofloxacin; Enoxacin; Humans; Imipenem; In Vitro Techniques; Infant, Newborn; Moxalactam; Naphthyridines; Quinolines; Serum Albumin; Thienamycins | 1985 |
Kinetics and action of N-methylthiotetrazole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety.
Topics: Azoles; Cefoperazone; Cefotetan; Cephalosporins; Cephamycins; Humans; Hypoprothrombinemias; Moxalactam; Population Surveillance; Risk Factors; Tetrazoles | 1988 |
Bacterial meningitis: is there a "best" antimicrobial therapy?
Topics: Cefoperazone; Ceftazidime; Ceftriaxone; Cefuroxime; Cephalosporins; Child; Humans; Infant, Newborn; Meningitis; Meningitis, Haemophilus; Moxalactam | 1987 |
[Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Ceftazidime; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas; Ticarcillin | 1987 |
Transcervical amnioinfusion of antibiotics: a basic study for managing premature rupture of membranes.
Topics: Amnion; Anti-Bacterial Agents; Catheterization; Cefoperazone; Cefotaxime; Cervix Uteri; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Humans; Moxalactam; Pregnancy | 1988 |
[Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol].
Topics: Aldehyde Oxidoreductases; Azoles; Biotransformation; Cefmetazole; Cefoperazone; Cephalosporins; Cephamycins; Disulfiram; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Middle Aged; Moxalactam; Tetrazoles | 1987 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
Cefoxitin sensitivity as a marker for inducible beta-lactamases.
Topics: beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Gram-Negative Bacteria; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1986 |
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroidaceae; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Clostridium; Evaluation Studies as Topic; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1986 |
Non-competitive inhibition of the alcohol dehydrogenase activity in rat liver by latamoxef, cefamandole or cefoperazone.
Topics: Alcohol Oxidoreductases; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Female; In Vitro Techniques; Kinetics; Liver; Moxalactam; Rats; Rats, Inbred Strains | 1986 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
Effect of the topical application of some newer antibiotics on the cerebral cortex.
Topics: Animals; Anti-Bacterial Agents; Bacitracin; Cats; Cefoperazone; Cefotaxime; Cerebral Cortex; Metronidazole; Moxalactam; Piperacillin | 1987 |
Pharmacokinetics of cefotaxime, moxalactam, and cefoperazone in the early puerperium.
Topics: Adult; Cefoperazone; Cefotaxime; Female; Humans; Injections, Intravenous; Kinetics; Moxalactam; Postpartum Period; Pregnancy | 1986 |
[Disulfiram-like reactions resulting from the administration of cephem antibiotics with methyltetrazolethiol moiety examined by using different doses].
Topics: Acetaldehyde; Aldehyde Oxidoreductases; Animals; Cefoperazone; Disulfiram; Ethanol; Fatty Liver; Liver; Male; Moxalactam; Rats; Rats, Inbred Strains | 1986 |
The effect of control on the pattern of utilization of cefotaxime, moxalactam and cefoperazone in a teaching hospital.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Hospitals, Teaching; Humans; Medical Records; Moxalactam; Pharmacy Service, Hospital; Premedication; Retrospective Studies | 1985 |
Cefmetazole: clinical evaluation of efficacy and safety in Japan.
Topics: Adolescent; Adult; Aged; Aging; Aldehyde Oxidoreductases; Animals; Azoles; Bacterial Infections; Cefmetazole; Cefoperazone; Cephamycins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation; Ethanol; Humans; In Vitro Techniques; Infant; Japan; Macaca fascicularis; Male; Middle Aged; Moxalactam; Rats; Rats, Inbred Strains; Respiratory Tract Infections; Structure-Activity Relationship; Tetrazoles | 1985 |
Beta-lactamase-positive strains of Haemophilus influenzae: susceptibility to and inactivation of beta-lactam antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephamycins; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Piperacillin | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
Topics: Bile; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Half-Life; Humans; Kinetics; Moxalactam | 1985 |
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.
Topics: Adolescent; Adult; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Humans; Hydrogen-Ion Concentration; Moxalactam; Piperacillin; Pseudomonas aeruginosa; Sputum | 1985 |
Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
Topics: Adult; Anti-Bacterial Agents; Bacillus subtilis; Cefoperazone; Cefotaxime; Ceftizoxime; Escherichia coli; Female; Humans; Male; Moxalactam; Staphylococcus aureus | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Penetration and clearance of cefoperazone and moxalactam in pleural fluid.
Topics: Aged; Cefoperazone; Female; Half-Life; Humans; Infusions, Parenteral; Male; Moxalactam; Pleural Effusion | 1985 |
Effect of formulary restriction of cefotaxime usage.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefoperazone; Cefotaxime; Child; Child, Preschool; Drug Utilization; Female; Formularies, Hospital as Topic; Humans; Infant; Male; Medicine; Middle Aged; Moxalactam; Retrospective Studies; Specialization; Specialties, Surgical | 1985 |
Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Creatinine; False Positive Reactions; Humans; Moxalactam | 1984 |
Diffusibility of the newer cephalosporins into human interstitial fluids.
Topics: Adolescent; Adult; Blood Proteins; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Diffusion; Extracellular Space; Humans; Male; Middle Aged; Moxalactam; Protein Binding | 1984 |
[The third generation cephems for surgical infections].
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Evaluation; Humans; Moxalactam; Surgical Wound Infection | 1984 |
The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
Topics: Adolescent; Adult; Bacteria; Cefoperazone; Cefotaxime; Humans; Male; Microbial Sensitivity Tests; Moxalactam; Neutropenia | 1984 |
Comparative pharmacokinetics of four new cephalosporins: moxalactam, cefotaxime, cefoperazone and ceftazidime in neonates.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Moxalactam | 1984 |
N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia.
Topics: Animals; Anti-Bacterial Agents; Azoles; Bacteria; Biotransformation; Cefamandole; Cefoperazone; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Glutamates; Glutamic Acid; Humans; Hypoprothrombinemias; Intestines; Moxalactam; Prothrombin; Rats; Structure-Activity Relationship; Tetrazoles | 1983 |
In vitro combination effects of cefsulodin, moxalactam and cefoperazone with four aminoglycosides on nonfermenting nosocomial gram-negative bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefsulodin; Cephalosporins; Cephamycins; Drug Interactions; Humans; Moxalactam | 1982 |
In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
Topics: Cefoperazone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1982 |
Third-generation cephalosporins in the treatment of pneumonia due to Pseudomonas aeruginosa in guinea pigs.
Topics: Animals; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Guinea Pigs; Moxalactam; Pneumonia; Pseudomonas Infections; Ticarcillin; Tobramycin | 1982 |
Disulfiram-like reaction to certain cephalosporins.
Topics: Adolescent; Adult; Aged; Cefamandole; Cefoperazone; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Female; Humans; Male; Moxalactam | 1983 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Staphylococcus; Streptococcus; Ticarcillin | 1980 |
In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Lactams; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 1980 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis; Moxalactam; Rabbits; Sulfamethoxazole; Trimethoprim | 1981 |
Potential value of cefoperazone in bacterial meningitis: experimental studies.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis, Haemophilus; Moxalactam; Rabbits | 1981 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
[Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Moxalactam | 1982 |
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam | 1982 |
[Statistical regression analysis for four new cephalosporins (author's transl)].
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Regression Analysis | 1982 |
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Gentamicins; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Cephamycins; Humans; Kinetics; Middle Aged; Models, Biological; Moxalactam; Myelography; Protein Binding; Time Factors | 1982 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Drug Resistance, Microbial; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Neisseria; Pseudomonas; Staphylococcus aureus; Streptococcus | 1983 |
Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbenicillin; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporinase; Gram-Negative Bacteria; Moxalactam; Penicillinase; Piperacillin | 1983 |
Entry of four cephalosporins into the ovine lung.
Topics: Albumins; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Lung; Lymph; Moxalactam; Proteins; Sheep | 1984 |
Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cell Membrane Permeability; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1983 |
Measurement of levels of aminoglycosides and vancomycin in serum in the presence of new beta-lactam antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Humans; Immunoenzyme Techniques; Mezlocillin; Moxalactam; Penicillins; Piperacillin; Vancomycin | 1984 |
[Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftizoxime; Drug Resistance, Microbial; Moxalactam; Sputum; Suppuration; Urine | 1984 |
Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
Topics: Aged; Bacteria; Blood Coagulation Factors; Cefazolin; Cefmetazole; Cefoperazone; Ceftazidime; Cephalosporins; Cephamycins; Female; Hemorrhage; Humans; Injections, Intravenous; Intestines; Male; Moxalactam; Vitamin K; Vitamin K Deficiency | 1984 |
Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Cefamandole; Cefoperazone; Cephalosporins; Cephalothin; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1980 |
Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Topics: beta-Lactamases; Cefoperazone; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Haemophilus; Haemophilus influenzae; Humans; Moxalactam | 1980 |
Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Moxalactam | 1981 |
Drugs recently released in Belgium.
Topics: Cefoperazone; Humans; Moxalactam | 1984 |
[The activity of moxalactam against Enterobacteriaceae and anaerobia in vitro].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefoperazone; Enterobacteriaceae; Escherichia coli; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus; Thienamycins | 2016 |